Birchview Capital, LP Q3 2023 significant ownership

Add to watchlist

Birchview Capital, LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Birchview Capital, LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SOLENO THERAPEUTICS INCMarch 19, 2019742,6352.3%
YIELD10 BIOSCIENCE, INC.December 29, 2017186,0792.2%
HANSEN MEDICAL INCFebruary 16, 2016? ?
METABOLIX, INC.June 23, 2015749,6962.8%

Compare quarters

Export Birchview Capital, LP's holdings

CSVXLS